Income Taxes (Details Narrative) - USD ($) |
12 Months Ended | ||
|---|---|---|---|
Dec. 22, 2017 |
Dec. 31, 2020 |
Dec. 31, 2019 |
|
| Effective income tax rate reconciliation, percent | 35.00% | 21.00% | 21.00% |
| Effective income tax rate reconciliation, deduction, percent | 80.00% | ||
| Net operating loss carryovers | $ 375,733 | $ 534,136 | |
| Change in valuation allowance | $ (137,747) | $ 178,630 | |
| Federal and State [Member] | |||
| Income tax reconciliation description | As of December 31, 2020, the Company had approximately $1,482,474 of federal and state net operating loss carryovers ("NOLs"). From this amount, $1,087,661 expire after 20 years, and can be carried back 2 years, according to the old tax law, while $394,813 can be carried forward indefinitely and cannot be carried back, in accordance with the new tax rules. | ||
| Net operating loss carryovers | $ 1,482,474 | ||
| Net operating loss carryforwards subject to expiration | $ 1,712,650 | ||
| X | ||||||||||
- Definition Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards that are subject to expiration dates. No definition available.
|
| X | ||||||||||
- Definition Percentage of domestic federal statutory tax rate applicable to pretax income (loss). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Percentage of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operations attributable to deduction. Includes, but is not limited to, dividend deduction, deduction for dividend paid to employee stock ownership plan (ESOP), Medicare prescription drug benefit subsidy deduction, and other deductions. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition A brief description of status of the tax examination, significant findings to date, and the entity's position with respect to the findings. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|